Paloma Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,758
| Closed | -$248K | – | 1580 |
|
|
2019
Q2 | $248K | Sell |
11,758
-6,473
| -36% | -$137K | ﹤0.01% | 1165 |
|
|
2019
Q1 | $373K | Buy |
+18,231
| New | +$373K | 0.01% | 900 |
|
|
2018
Q4 | – | Sell |
-11,600
| Closed | -$223K | – | 991 |
|
|
2018
Q3 | $223K | Buy |
+11,600
| New | +$223K | ﹤0.01% | 1058 |
|
|
2018
Q1 | – | Sell |
-10,261
| Closed | -$197K | – | 1393 |
|
|
2017
Q4 | $197K | Buy |
+10,261
| New | +$197K | ﹤0.01% | 1138 |
|
|
2017
Q3 | – | Sell |
-24,680
| Closed | -$441K | – | 1472 |
|
|
2017
Q2 | $441K | Sell |
24,680
-34,066
| -58% | -$609K | 0.01% | 1147 |
|
|
2017
Q1 | $852K | Buy |
58,746
+27,884
| +90% | +$404K | 0.01% | 890 |
|
|
2016
Q4 | $568K | Buy |
+30,862
| New | +$568K | 0.01% | 1030 |
|